Results 101 to 110 of about 865 (113)

The wrongful indictment of pre-referral rectal artesunate further delays the roll-out of this lifesaving drug

Lancet Infectious Diseases, The, 2023
Lorenz Von Seidlein
exaly  

In vitro release and stability of an artesunate rectal gel suitable for pediatric use

International Journal of Pharmaceutics, 2008
Karen Gaudin, Pascal Millet, Fawaz Fawaz   +2 more
exaly  

Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study

Lancet, The, 2004
Francesca Little, M E Molyneux, K I Barnes   +2 more
exaly  

The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria

British Journal of Clinical Pharmacology, 2002
Kenneth F Ilett, Kevin T Batty, Shane M Powell   +2 more
exaly  

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial

Lancet, The, 2009
Ma Faiz, John O Gyapong, M Warsame
exaly  

Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis

Lancet, The, 2010
Yesim Tozan, Eili Y Klein, Ramanan Laxminarayan   +2 more
exaly  

Pre-referral rectal artesunate: no cure for unhealthy systems

Lancet Infectious Diseases, The, 2023
exaly  

Assessing the cost–effectiveness of prereferral rectal artesunate for treatment of severe childhood malaria

Expert Review of Pharmacoeconomics and Outcomes Research, 2011
Lesong Conteh, Shunmay Yeung
exaly  

Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children

Acta Tropica, 2003
E A Gomez
exaly  

Health system readiness and the implementation of rectal artesunate for severe malaria in sub-Saharan Africa: an analysis of real-world costs and constraints

The Lancet Global Health, 2023
exaly